Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Parahelops cf. quadricollis MSL2007

Known as: Parahelops sp. PAM3 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Adjuvant incorporated lipid nanoparticles for enhanced mRNA-mediated cancer immunotherapy.
For mRNA mediated cancer immunotherapy, Pam3 was incorporated as an adjuvant within lipid nanoparticles (LNPs) with OVA mRNA. The… Expand
2018
2018
Immune synergistic oligodeoxynucleotide from Lactobacillus rhamnosus GG enhances the immune response upon co-stimulation by bacterial and fungal cell wall components.
Bacterial genomic DNA has recently been shown to elicit a highly evolved immune defense. This response can be selectively… Expand
2017
2017
Demonstration and application of 37.5 Gb/s duobinary-PAM3 in PONs
Duobinary-PAM3 enables up to 37.5Gb/s with 10G receivers. It has less linearity requirements on transmitters and gains 2dB… Expand
  • figure 1
  • figure 2
2015
2015
Toll‐like receptor 2 activators modulate oral tolerance in mice
Toll‐like receptor 2 (TLR2) is a widely expressed pattern recognition receptor critical for innate immunity. TLR2 is also a key… Expand
2015
2015
Heterodimer‐specific TLR2 stimulation results in divergent functional outcomes in B‐cell precursor acute lymphoblastic leukemia
Reports of spontaneous acute lymphoblastic leukemia (ALL) remissions following severe bacterial infections suggest that bacterial… Expand
2014
2014
Immune and Anticancer Responses Elicited by Fully Synthetic Aberrantly Glycosylated MUC1 Tripartite Vaccines Modified by a TLR2 or TLR9 Agonist
The mucin MUC1 is overexpressed and aberrantly glycosylated by many epithelial cancer cells manifested by truncated O‐linked… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE